Blog
RSS FeedPosted by Michael Wonder on 05 May 2022
Your money or your life - the high cost of cancer drugs under Medicare Part D
4 May 2022 - The financial burden associated with orally administered anti-cancer drugs can be overwhelming for Medicare beneficiaries. ...
Posted by Michael Wonder on 19 Apr 2022
Medicare’s decision not to fund Aduhelm changes landscape for US pharma industry
19 April 2022 - The decision by the agency responsible for Medicare to restrict coverage of Biogen’s Alzheimer’s drug aducanumab ...
Posted by Michael Wonder on 19 Apr 2022
Prioritising reference products over biosimilars led to millions of missed savings for Part D
20 April 2022 - Medicare Part D plans missed out on between $84 million and $143 million in savings by ...
Posted by Michael Wonder on 07 Apr 2022
CMS finalises Medicare coverage policy for monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease
7 April 2022 - Today, the CMS released a national policy for coverage of aducanumab (Aduhelm) and any future monoclonal antibodies ...
Posted by Michael Wonder on 06 Apr 2022
Inside a campaign to get Medicare coverage for a new Alzheimer’s drug
6 April 2022 - The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and ...
Posted by Michael Wonder on 07 Mar 2022
Medicare bulk billing rates surge across our health system
6 March 2022 - Essential medical care is more affordable than ever before with the number of Australians receiving essential medical ...
Posted by Michael Wonder on 10 Feb 2022
Biogen urges Medicare to reverse proposed limits on coverage of Alzheimer's drug
11 February 2022 - Biogen is urging Medicare to broadly reimburse its recently authorised Alzheimer's drug, in response to a ...
Posted by Michael Wonder on 04 Feb 2022
Biden-Harris Administration will cover free over the counter COVID-19 tests through Medicare
3 February 2022 - As part of the Biden-Harris Administration’s ongoing efforts to expand Americans’ access to free testing, people in ...
Posted by Michael Wonder on 08 Jan 2022
CMS takes action to lower out of pocket Medicare Part D prescription drug costs
6 January 2022 - Today, the Centers for Medicare & Medicaid Services issued a proposed rule that would make updates to ...
Posted by Michael Wonder on 14 Dec 2021
Permanent telehealth to strengthen universal Medicare
13 December 2021 - The Australian Government is investing $308.6 million to strengthen Australia’s primary care health system, building on our ...
Posted by Michael Wonder on 24 Nov 2021
Califf, Biden’s pick to lead FDA, has millions invested in pharma and tech companies
23 November 2021 - Robert Califf, President Biden’s choice to lead the FDA, earned $2.7 million as an executive at ...
Posted by Michael Wonder on 23 Nov 2021
Medicare coverage of aducanumab — implications for state budgets
20 November 2021 - CMS is considering whether and under what circumstances Medicare will pay for aducanumab for Alzheimer’s disease. ...
Posted by Michael Wonder on 15 Nov 2021
It's time for Congress to get Medicare drug pricing reform right
15 November 2021 - After a three-year debate and delay in delivering patients much-needed relief from high out-of-pocket prescription drug costs, ...
Posted by Michael Wonder on 15 Nov 2021
Medicare premiums to jump in part due to pricey Alzheimer's drug
12 November 2021 - Seniors on Medicare will have to pay more than $20 more per month extra in premiums ...
Posted by Michael Wonder on 03 Nov 2021
Democrats revive drug pricing reform with a narrow set of proposed measures
2 November 2021 - On Tuesday 2 November, Senator Schumer announced that an agreement had been reached regarding lowering drug ...